Company: OSRH
Filing Date: 2025-01-29
Form Type: S-4/A
Source: 0001213900-25-007923
Chunk: 543

Company: OSR Holdings, Inc.
Filing Date: 2025-01-29
Form: S-4/A
Chunk 543
---
 of their requests by emailing or writing us at our principal executive offices at group@bellevuecm.com or 10900 NE 4 thStreet, Suite 2300, Bellevue, WA 98004. Transfer Agent and Register The transfer agent for the securities of BLAC is Continental Stock Transfer & Trust Company. LEGAL MATTERS The validity of the shares of BLAC Common Stock to be issued in connection with the Business Combination and the material U.S. federal income tax consequences of the Business Combination will be passed upon by K&L Gates LLP. EXPERTS The financial statements of Bellevue Life Sciences Acquisition Corp. as of December 31, 2023 and 2022 included in this proxy statement/prospectus have been so included in reliance on the report of WithumSmith+Brown, PC, an independent registered public accounting firm, which includes an explanatory paragraph as to the ability of Bellevue Life Sciences Acquisition Corp. to continue as a going concern, upon the authority of said firm as experts in accounting and auditing. The financial statements of OSR Holdings Co., Ltd. as of December31, 2022 and 2023 and Darnatein Co., Ltd. as of December31, 2021 and 2022 included in this proxy statement/prospectus have been so included in reliance upon the report of RSM Shinhan Accounting Corporation independent registered public accountants. 344 WHERE YOU CAN FIND MORE INFORMATION We file reports, proxy statements and other information with the SEC as required by the Exchange Act. You can read BLAC’s SEC filings, including this proxy statement/prospectus, over the Internet at the SEC’s website at http://www.sec.gov. If you would like additional copies of this proxy statement/prospectus or if you have questions about the Business Combination or the proposals to be presented at the BLAC’s Stockholders’ Meeting, you should contact us at the following address or by email: Bellevue Life Sciences Acquisition Corp.
10900 NE 4 thStreet, Suite 2300
Bellevue, WA 98004
Attn: Jun Chul Whang
Email: group@bellevuecm.com
jcwhang@bellevuecm.com You may also obtain these documents by requesting them in writing or by telephone from our proxy solicitation agent at the following address and telephone number: Advantage Proxy, Inc.
P.O. Box 10904
Yakima, WA 98909
Attn: Karen Smith
Toll Free Telephone: (